-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on MDxHealth, Lowers Price Target to $2

Benzinga·08/21/2026 12:01:12
Listen to the news
BTIG analyst Mark Massaro maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the price target from $4 to $2.